perhexiline maleate April 12, 2017 perhexiline maleate Trade Name Orphan Indication Moderate to severe symptomatic hypertrophic cardiomyopathy USA Market Approval USA USA Designation Date 2012-06-14 00:00:00 Sponsor Heart Metabolics, Limited.;88 Harcourt Street, Dublin 2;